The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 10, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

September 30, 2019

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Choline alfoscerate

Treatment duration is 6 months and can be extended to 12 months with participant's agreement.

DRUG

Placebo

Treatment duration is 6 months and can be extended to 12 months with participant's agreement.

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT03249259 - The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With Diabetes | Biotech Hunter | Biotech Hunter